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ABSTRACT  
The development of targeted nanocarriers able to be selectively internalized within tumoral cells 
and therefore, to deliver antitumoral drugs specifically to diseased cells, constitutes one of the 
most important goals in nanooncology. Herein, the development of Janus mesoporous silica 
particles asymmetrically decorated with two targeting moieties, one of them selective to folate 
membrane cell receptors (folic acid) and the other one able to bind to mitochondria membrane 
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(triphenylphospine) is described in order to achieve a sequential cellular to organelle 
vectorization. The asymmetric decoration of each side of the particle allows a finest control in 
the targeting attachment process in comparison with the use of symmetric nanocarriers. The 
presence of folic acid induces a higher increase in particle accumulation inside tumoral cells and 
once there, these nanocarriers are guided close to mitochondria by the action of the TPP moiety. 
This strategy can be applied for improving the therapeutic efficacy of current nanomedicines. 
INTRODUCTION 
The paramount discovery carried out in 1986 by Maeda and Matsumura about the natural 
tendency of nanometric systems to be passively accumulated within solid tumors
1
 triggered the 
race to design nanocarriers able to deliver antitumoral agents specifically into diseased tissues.
2,3 
Neoplastic tissues are irrigated by blood vessels which have been built in a chaotic way so that 
they usually exhibit fenestrations with diameters around a few hundred of nanometers.
4 
Therefore, when the nanocarrier reaches the tumoral area, it is able to pass through these pores 
reaching the tumoral tissue whereas it cannot cross the healthy vessel walls. Additionally, the 
rapid expansion of tumoral cells compresses the nearby located lymphatic vessels compromising 
the drainage which enhances the accumulation time of nanocarriers into the diseased zone. This 
phenomenon, called EPR (Enhanced Permeation and Retention) effect, has also been so-called 
as primary targeting being the responsible for nanocarrier accumulation in tumoral tissues. 
However, this solely effect is not enough to achieve an improved therapeutic response over 
conventional therapy. Tumoral masses are incredibly complex tissues which are formed by a 
myriad of different cells (cancerous, supportive, immune cells and so on)
5
 Therefore, the 
capacity to distinguish between malignant and healthy cells is necessary for improving the 
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effectiveness of nanomedicines. In order to acquire this property, the external surface of 
nanocarriers can be decorated with certain moieties such as antibodies,
6
 aptamers,
7
 vitamins,
8
 
peptides
9
 or synthetic molecules,
10
 which are recognized by specific membrane cell receptors 
overexpressed by the tumoral cells. The presence of these targeting agents (called secondary 
targeting) enhances the accumulation within the tumoral cell. Additionally, two targeting 
moieties can be anchored on the same nanocarrier in order to enhance even more the selectivity 
of the nanodevice.
11-13
  It is also possible to control the nanoparticle trafficking within the cell 
placing targeting moieties able to recognize organelles such as mitochondria or cell nucleus 
(tertiary targeting).
14
 Therefore, different tertiary targeting agents have been attached on drug 
loaded nanoparticles achieving significant improvements in the therapeutic efficacy of the 
transported payloads.
15
 In sight of these results, the possibility to design systems which combines 
these targeting capacities (tissular, cellular and organelle) has aroused great attention in the 
scientific community for improving even more the capacity to destroy tumoral cells limiting the 
side effects and systemic toxicity of the therapy. Thus, it has been reported engineered peptides 
which carry specific cellular and organelle targeting devices,
16
 nanoparticles doubly 
functionalized with both targeting agents
17
 and also nanocarriers functionalized with hierarchical 
targeting devices which recognize specific membrane cellular receptors and certain organelles 
following an activatable tandem mechanism.
18
 However, in many cases, they lack of a precise 
control in the targeting ratio, have low transport capacity or requires the synthesis of complex 
moieties. Recently, Ma and co-workers have carried out a computational study in order to 
determine the best configuration of the targeting moieties in dual-targeted nanocarriers 
concluding that Janus-type structures achieved the fastest engulfment by the cell membrane, 
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regardless the physicochemical properties and the separation between the targeting group and the 
carrier surface.
19 
 
Herein, we describe an easy procedure for the synthesis of Janus mesoporous silica 
nanoparticles (J-MSN) which carry two different targeting moieties, cell and organelle targeting 
moiety, respectively, each located in one hemisphere of the particle (Figure 1). Mesoporous 
silica nanoparticles (MSN) present great cargo capacity, excellent biocompatibility and easy and 
cheap production.
20,21
 In the approach here presented, one of the hemisphere of MSN was 
decorated with folic acid which act as cellular targeting agent due to the fact that many tumoral 
cell lines usually overexpress folate receptor.
22
 On the other hemisphere, a triphenylphospine 
derivative (TPP) was anchored for directing the nanocarrier to the mitochondria membrane 
exploiting the affinity of this positively charged group for the highly negative mitochondria 
membrane.
23
 The efficacy of this device has been evaluated using human prostate cancer cells 
(LNCaP), which present higher expression of folate-binding proteins on their membrane.
24,25
 
This system showed an enhanced accumulation in tumoral cells in comparison with a control line 
composed by healthy pre-osteoblastic cells (MC3T3-E1) which do not present a overexpression 
of folate-binding proteins. Additionally, the presence of TPP on the particle surface leads to a 
selective accumulation of the nanoparticles close to mitochondria. Finally, when the carriers 
were loaded with topotecan (TOP), a potent DNA topoisomerase inhibitor which induces nuclear 
and mitochondria DNA damage,
26
 the double targeted device exhibit significant higher toxicity 
in comparison with the particles decorated only with one of the targeting moieties, which point 
out that the TOP effect is stronger when it is released close to mitochondria. These results 
indicate that the use of J-MSN decorated with cellular and organelle targeting agents can 
significantly improve the efficacy of the transported drugs in antitumoral therapies. 
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Figure 1. Mechanism of action of dual targeted MSN: cellular and mitochondria targeting. 
EXPERIMENTAL SECTION 
Materials and Methods 
The following compounds were purchased from Sigma-Aldrich Inc.: 
aminopropyltriethoxysilane (APTES), ammonium nitrate, cetyltrimethylammonium bromide 
(CTAB), tetraethyl orthosilicate (TEOS), dicyclohexylcarbodiimide (DCC), N-
hydroxysuccinimide (NHS), N-diisopropylethylamine (DIPEA), fluorescein isothiocyanate 
(FITC), folic acid, succinic anhydride,  4-carboxy-1-(triphenyl-l4-phosphanyl)butan-1-ylium 
bromide, topotecan hydrochloride hydrate (TOP, >98%) and trifluoroacetic acid (TFA).  All 
other chemicals (absolute ethanol, DMF, DMSO, acetone, ethyl ether, dichloromethane (DCM), 
heptane, dry solvents etc.) were commercially available and of best quality and they were 
employed as received. 
Characterization techniques  
Fourier transform infrared spectroscopy (FTIR) was performed using a Thermo Nicolet nexus 
equipped with a Goldengate attenuated total reflectance device. The textural properties of the 
Page 5 of 31
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 6
materials were determined by nitrogen sorption porosimetry using a Micromeritics ASAP2010 
instrument. Prior to perform the N2 measurements, the samples were degassed under vacuum for 
24 h at room temperature. Thermogravimetry analysis (TGA) was performed using a Perkin 
Elmer Pyris Diamond TG/DTA analyser with a 5 
o
C · min
-1
 heating ramp from room temperature 
to 600 
o
C. The hydrodynamic size of the mesoporous nanoparticles was measured by means of a 
Zetasizer Nano ZS (Malvern Instruments) equipped with a 633 nm ‘‘red’’ laser. Mass spectra 
were acquired using a Voyager DE-STR Biospectrometry MALDI-TOF mass spectrometer. 
Scanning electron microscopy (SEM) analyses were performed on a JEOL 6400-LINK 
AN10000 microscope (Electron Microscopy Centre, UCM). The samples underwent the Au 
metallization prior to observation. Liquid NMR experiments were performed using a Bruker AV 
250 MHz. 
Synthesis of (2,2-dimethyl-4,15-dioxo-3,8,11-trioxa-5,14-diazanonadecan-19-
yl)triphenylphosphonium bromide (TPP-NH2) 
To a solution of 4-carboxy-1-(triphenyl-l4-phosphanyl)butan-1-ylium bromide (250 mg) and 
N-hydroxysuccinimide (130 mg, 2 eq) in 3 mL of DMF, DIC (260mg, 3 eq) and DIPEA (1.2 mL, 
6 eq) were added under inert atmosphere. The mixture was stirred during 4 hours at room 
temperature.  When the acid activation was finished, a solution of tert-butyl (2-(2-(2-
aminoethoxy) ethoxy)ethyl)carbamate (303 mg, 1.1 eq) was added dropwise. The mixture was 
stirred overnight. Crude was precipitated in cool ether and the filtrated solid was purified by 
flash column chromatography (chloroform/MeOH 4:1). The resulting product was characterized 
by 1H NMR (250 MHz, CDCl3) δ 8.24 (t, J = 5.3 Hz, 1H, NH, amide), 7.89 – 7.76 (m, 9H, 
TPP), 7.76 – 7.63 (m, 6H, TPP), 5.18 (s, 1H, NH-Boc), 3.72 (dd, J = 14.0, 7.0 Hz, 2H), 3.59 – 
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3.47 (m, 8H), 3.40 (dd, J = 11.9, 6.2 Hz, 2H), 3.34 – 2.61 (m, 1H), 2.70 – 2.57 (m, 1H), 2.03 – 
1.84 (m, 2H, CH2), 1.80 – 1.55 (m, 6H, 3xCH2), 1.42 (s, 9H, 3xCH3, Boc).  
The next step was the removal of Boc-protecting group which was carried out dissolving the 
product in 2 mL of DCM/TFA (1%) and stirring during two hours. Crude was precipitated in 
cool ether and the filtrated solid was purified by flash column chromatography 
(chloroform/MeOH 4:1). The resulting product was characterized by 1H NMR (250 MHz, 
CDCl3) δ 8.53 (bs, 2H, NH2), 8.23 (s, 1H, NH, amide), 7.89 – 7.76 (m, 9H, TPP), 7.76 – 7.63 
(m, 6H, TPP), 3.85 (bs, 2H), 3.59 – 3.47 (m, 8H), 3.40 (bs, 2H), 3.21 (bs, 1H), 2.70 – 2.57 (m, 
1H), 1.94 (m, 2H, CH2), 1.80 – 1.55 (m, 6H, 3xCH2).  
Synthesis of fluorescent MSN 
Prior, FITC (1 mg) and APTES (2.2 µL) were dissolved in the minimum volume of EtOH and 
the mixture was stirred at room temperature for 2 hours under a N2 atmosphere. The resulting 
solution was called Solution 1. 
MSN were synthesized as following: to a 1 L round-bottom flask, 1 g of CTAB as a structure-
directing agent, 480 mL of H2O (Milli-Q), 3.5 mL of NaOH (2 M) were added. The mixture was 
heated to 80ºC and stirred at 600 rpm. When the reaction mixture was stabilized at 80 
o
C, 5 mL 
of TEOS were mixed with solution 1 and the resulting solution was added dropwise at 
0.33mL/min rate. The pale yellow suspension obtained was stirred during further 2h at 80 
o
C. 
The reaction mixture was filtered and washed 3 times with 100 mL of H2O, and then ones with 
50 mL of EtOH. Finally, the surfactant was removed by ionic exchange using a solution of 
amonium nitrate (10 mg·mL
-1
) in 400 mL of ethanol (95%) at 65 
o
C overnight with magnetic 
stirring under reflux. This procedure was repeated twice in order to eliminate completely the 
surfactant. 
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Synthesis of aminated mesoporous silica particles (MSN-NH2) 
200 mg of the dried MSN particles were vortexed during 80 seconds with a mixture of 1 g 
molten paraffin in 11.6 mL H2O, 4.4 mL EtOH and 2 mg of CTAB at 70 
o
C. After this time, the 
suspension was immediately cooled down in order to solidify the paraffin. The obtained particles 
were filtered, washed and subsequently dispensed in 14 mL EtOH containing 1.5 mL NH3 (aq., 
25%). After addition of 0.47 mL APTES (2 mmol), the mixture was shaken overnight on an 
orbital shaker at room temperature. The solid was filtered and washed with heptane until there 
was no paraffin residue measured by FTIR. 
Uniformly aminated MSN were synthesized as control by the following synthetic procedure, 
TEOS (4.5 mL) and APTES (0.5 mL) were mixed and added dropwise to solution of 1 g of 
CTAB, 480 mL of water and 3.5 mL of 2 M NaOH at 80 
o
C. The final reaction mixture was 
stirred at 80 
o
C for 2 hours. A white solid was filtered and washed with water and EtOH. 
Synthesis of carboxylic acid-functionalized particles (MSN-CO2H) 
200 mg of MSN-NH2 particles were suspended in 10 mL of dry THF under N2 gas as inert 
atmosphere. To this solution, 40 mg succinic acid was added and the mixture was stirred at room 
temperature overnight.  The obtained particles were filtered and washed with THF. 
Synthesis of amino-carboxylic acid particles (H2N-MSN-CO2H) 
130 mg of MSN-CO2H previously dried under vacuum were suspended in dry toluene under 
N2 gas and 0.15 mL of APTES was added. The mixture was refluxed at 110 
o
C overnight under 
inert atmosphere. The obtained particles were filtered and washed with toluene and ethyl ether. 
Synthesis of Folic-MSN-CO2H 
22 mg of folic acid (50 mmol) were dissolved in 2 mL of dry DMF/DMSO (4:1). 36 mg of 
DCC and 38 mg of NHS were added to this solution and the mixture was stirred at room 
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temperature during 30 min under N2 atmosphere. After this time, the solution was added to a 
suspension of 50 mg of dried H2N-MSN-CO2H in 3 mL of DMF/DMSO (4:1). The resulting 
suspension was stirred under N2 atmosphere overnight. The obtained particles were filtered and 
washed with DMF/DMSO (4:1), water and acetone. 
Synthesis of H2N-MSN-TPP 
100 mg of H2N-MSN-CO2H were suspended in 2 mL of dry DMF which contain 12 mg of 
DCC and 13 mg of NHS. 41 mg of the TPP derivative were dissolved in 1 mL of dry DMF 
which contains 5 µL of DIPEA and this solution was added to the particle suspension. The 
resulting mixture was stirred overnight under N2 atmosphere. The obtained particles were filtered 
and washed with DMF, water and acetone. 
Synthesis of Folic-MSN-TPP 
22 mg of folic acid (50 mmol) were dissolved in 2 mL of dry DMF/DMSO (4:1). 36 mg of 
DCC and 38 mg of NHS were added to this solution and the mixture was stirred at room 
temperature during 30 min under N2 atmosphere. After this time, the solution was added to a 
suspension of 50 mg of dried H2N-MSN-TPP in 3 mL of DMF/DMSO (4:1). The resulting 
suspension was stirred under N2 atmosphere overnight. The obtained particles were filtered and 
washed with DMF/DMSO (4:1), water and acetone. 
TOP loading within MSN derivatives 
50 mg of each MSN (NH2-MSN-CO2H, MSN-Fol, MSN-TPP and Fol-MSN-TPP, 
respectively) were placed in a dark glass vial and dried at 80 
o
C under vacuum during 4 hours. 
After this time, 5 mL of an aqueous solution of TOP (3 mg·mL-1) were added and the 
suspension was stirred at room temperature for 48 h. The particles were filtered and the excess of 
TOP was removed by washing three times with water. The amount of drug loaded in each system 
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was determined from the difference between the fluorescence measurements of the initial and 
recovered solutions (λexc= 400, λem=540 nm). In all the cases, the amount of TOP loaded was 
around 5% in weight.   
Cell cultures 
Cell culture studies were performed using mouse osteoblastic cell line MC3T3-E1 (subclone 4, 
CRL-2593; ATCC, Mannassas, VA) and androgen-sensitive LNCaP cells, a human prostate 
cancer cell line (CRL-1740; ATCC, Mannassas, VA). The tested MSNs (6 µg/mL) were placed 
into each well of 6- or 24-well plates (CULTEK) after cell seeding. MC3T3-E1 and LNCaP cells 
were then plated at a density of 20.000 cells·cm
-2
 in 1 mL of alfa-minimum essential medium or 
Dulbecco’s modified Eagle’s medium (DMEM, Sigma Chemical Company), respectively, 
containing 10% of heat-inactivated fetal bovine serum and 1% penicillin (BioWhittaker 
Europe)–streptomycin (BioWhittaker Europe) at 37 ºC in a humidified atmosphere of 5% CO2, 
and incubated for different times. Some wells contained no MSNs as controls. 
Nanoparticle uptake studies by flow cytometry 
After 24h, the cells were incubated in the absence or presence of the tested MSNs (6µg/mL) 
during 2 hours. Cells were then washed twice with PBS and incubated at 37 ᵒC with trypsin–
EDTA solution for cell detachment. The reaction was stopped with culture medium after 5 min 
and cells were centrifuged at 1.500 rpm for 10 min and resuspended in fresh medium. Then, the 
surface fluorescence of the cells was quenched with trypan blue (0.4%) to confirm the presence 
of an intracellular, and therefore internalised, fluorescent signal. Flow cytometry measurements 
were performed at an excitation wavelength of 488 nm, green fluorescence was measured at 530 
nm (FL1). The trigger was set for the green fluorescence channel (FL1). The conditions for the 
data acquisition and analysis were established using negative and positive controls with the 
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CellQuest Program of Becton–Dickinson and these conditions were maintained during all the 
experiments. Each experiment was carried out three times and single representative experiments 
are displayed. For statistical significance, at least 10,000 cells were analyzed in each sample in a 
FACScan machine (Becton, Dickinson and Company, USA) and the mean of the fluorescence 
emitted by these single cells was used.  
Nanoparticle uptake studies by fluorescence microscopy  
Cells were incubated with the MSNs (6µg/mL) for 2h in serum-free culture medium. Then, the 
medium was withdrawn and cells were washed with PBS three times. Cells were incubated for 
45 minutes with MitoTracker® to stain mitochondria. Cells were washed, fixed with ethanol for 
2 min and stained with DAPI (40, 60 diamidino-2-phenylindole) at 1µg/mL. Fluorescence 
microscopy images were taken to evaluate MSNs. Green channel was used to locate for MSNs, 
blue for cell nucleus and red for mitochondria in a Evos FL Cell Imaging System equipped with 
tree Led Lights Cubes (lEX (nm); lEM (nm)): DAPI (357/44; 447/60), GFP (470/22; 525/50), 
RFP (531/40; 593/40) from AMG (Advance Microscopy Group). 
Cell viability after incubation with Topotecan-loaded MSN 
Cell growth was analyzed using the CellTiter 96AQueous Assay (Promega, Madison, WI, 
USA), a colorimetric method for determining the number of living cells in culture. Briefly, both 
type of cells were cultured as described above without (control) or with the corresponding 
amount of functionalized MSNs (100 µg·mL
-1
) and TOP-loaded MSNs (6 µg·mL
-1
), during 24 
hours and 6 hours respectively. In the case of empty MSN, the cells were analyzed after the 
incubation time. In the case of TOP-loaded MSN, after the 6 hours incubation time, cells were 
gently washed two times with PBS and they were incubated in cell culture medium during 48h 
more. 40 µL of CellTiter 96 AQueous One Solution Reagent (containing 3-(4,5-dimethythizol-2-
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yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-nyl)-2H-tetrazoliumsalt (MTS) and an electron 
coupling reagent (phenazine ethosulfate) that allows its combination with MTS to form a stable 
solution) was added to each well and incubated for 4h. The absorbance at 490 nm was then 
measured in a Unicam UV-500 UV–visible spectrophotometer.   
 
RESULTS AND DISCUSSION 
MSN were prepared following a previously reported modified Stöber method which 
incorporates fluorescein covalently attached within the silica matrix.
27
 The presence of this 
fluorophore is required in order to allow the easy monitorization of nanoparticle cell uptake by 
fluorescence microscopy and cytometry techniques. There are different strategies for the 
asymmetric functionalization of this type of mesoporous materials.
28
 In our case, MSN were 
decorated with amino groups on one hemisphere following a two-step process which employs 
wax-in-water Pickering emulsions.
29,30
 In this method, silica particles were added over a 
vigorously stirred aqueous emulsion of paraffin above the melting temperature of the wax (53-57 
o
C). After a short stirring time, the mixture was rapidly cooled at room temperature and the 
paraffin solidifies trapping the MSN particles on the surface (Figure 2b-c). The exposed MSN 
surface was functionalized with aminopropyltriethoxysilane (APTES) and finally, the paraffin 
was removed washing with heptane.  Following this method, fluorescent round-shaped MSNs 
(MSN-NH2) with size distribution centred on 190 nm as can be observed by transmission 
electron microscopy (TEM) were obtained (Figure 2d). In order to study the asymmetrization 
process, MSN-NH2 were mixed with gold nanoparticles (5 nm of diameter) in aqueous solution 
during 12 hours. After this time, the suspension was centrifuged at mild condition (5000 rpm and 
10 min) and the isolated particles were observed by TEM showing that the gold nanoparticles 
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were mainly located on one side of MSN due to the affinity of gold by amino groups which 
confirmed the asymmetric nanoparticle decoration (Figure 2e). When the same experiment was 
carried out with naked particles (MSN) the gold nanoparticles were not adsorbed on the silica 
surface remaining in the solution (Figure S1). Additionally, the percentage of nanoparticles 
which exhibited Janus structure was statistically determined by collecting several sets of TEM 
images showing that around 66% of particles were asymmetrically functionalized with amino 
groups (Figure S2 and Table S1 in supporting info). MSN completely decorated with amino 
groups were synthesized and treated with the gold nanoparticles in order employ them as control. 
In this case, the gold nanoparticles were uniformly distributed around the practically all the MSN 
(96%) which indicated a uniform distribution of the amino groups (Figure S3 and Table S1 in 
supporting information). Finally, the asymmetrization process was also confirmed by the 
hydrophilicity change in the particles after the introduction of amino groups which was 
monitored placing the particles in a vial which contains the same amount of an aqueous PBS 
solution (pH = 7.4) and dichloromethane. The particles uniformly functionalized with APTES, 
which are more hydrophobic, are located in the organic phase whereas the hydrophilic naked 
particles are placed in the aqueous phase. In the case of MSN-NH2, they are mainly placed in the 
interphase, which proved the dual nature of these particles (Figure S4). All these data support the 
good performance of the asymmetrization process and are in agreement with previously reported 
works.
29,30
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Figure 2. a) Scheme of asymmetrization pathway of MSN (red triangles represent APTES which 
is employed as amino source) b-c) SEM image of paraffin beads with MSN embedded, d)  TEM 
image of MSN-NH2 and e) TEM image of gold nanoparticles on one side of MSN-NH2. 
The asymmetrization process did not alter the particle morphology but it induced a slight 
hydrodynamic diameter increase (from 160 to 190 nm) according with dynamic light scattering 
(DLS) (Figure S5). Zeta potential measurement of the particles in phosphate buffer solution (pH 
7.2) showed a drastic change in surface charge, from negative value (-20,5 mV) of the naked 
particles to positive one (+22.4 mV) of aminated nanoparticles (Figure 3). This change confirms 
the presence of amino groups on the particle surface, because they are protonated at 
physiological pH. The precise amount of amino groups was determined by quantitative Fmoc 
protocol
31
 yielding a result of 100-130 µmol of amino groups per gram of MSN-NH2. In order to 
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attach the targeting agents each of them in a hemisphere of the particle, anchoring points with 
different reactivity should be incorporated in each side. Amino and carboxylic groups were 
selected because there are many synthetic procedures for grafting biomolecules to them.
32 
Therefore, the amino groups present in MSN-NH2 were derivatised to carboxylic acid by their 
reaction with succinic anhydride in organic solvent. Then, the remained silanol groups present in 
the free hemisphere of MSN-CO2H were react with APTES in order to introduce amino groups 
in the other side yielding the asymmetrically functionalized NH2-MSN-CO2H (Scheme 1). 
 
Scheme 1. Synthetic pathway for the synthesis of asymmetrically functionalized MSN, i) 
Paraffin/CTAB/EtOH/H2O/NH3 (aq)/APTES, ii) succinic ahydride/THF, iii) 
APTES/Toluene/reflux, iv) DMF/DMSO/DCC/NHS, v) DMF/DCC/NHS/DIPEA and vi) 
DMF/DMSO/DCC/NHS. 
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The complete synthetic process was monitored by Zeta potential measurements (Figure 3). The 
transformation of the amino groups of MSN-NH2 into carboxylic groups leads to a strong 
decrease in the positive charge (MSN-CO2H) which is partially re-established when new amino 
groups are introduced in the free hemisphere (NH2-MSN-CO2H). The attachment of folic acid 
was carried out in the NH2 side employing the well-known carbodiimide chemistry. The 
carboxylic group of the folic acid was activated by reaction with dicyclohexylcarbodiimide 
(DCC) and N-hydrosuccinimide (NHS) and then, the resulting ester was directly added to a 
suspension of NH2-MSN-CO2H yielding MSN-Fol. After this step, the surface charge of the 
particle changed back to negative value which is the consequence of the reduction of free amino 
groups on the particle surface. In the case of the attachment of TPP moieties, a specific TPP 
analogue which carry one amino group at the end (TPP-NH2) was synthesized (see experimental 
section for more details). These TPP moieties were introduced following a similar procedure but, 
in this case, through the activation of the carboxylic groups of NH2-MSN-CO2H with DCC and 
NHS followed by the subsequent addition of TPP-NH2. As it was expected, surface charge 
suffered a significant increase after this synthetic step due to the introduction of positive charges 
on the particle surface. Finally, Folic acid was anchored to the free amino groups of MSN-TPP 
leading to a dramatic reduction of the charge. Additionally, the introduction of each targeting 
agent was confirmed measuring the amount of organic material by thermogravimetric analysis, 
before and after the grafting step (Table below Figure 3) and also by FTIR spectroscopy, which 
shows the apparition of characteristic bands after each synthetic step (Figure S6). 
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Figure 3. Upper figure represents Zeta potential measurements of functionalized MSN 
derivatives. Lower Table shows the increment in amount of organic material after the grafting 
step (*). 
Human prostate cancer cells (LNCaP) were selected as tumoral model cell line due to the 
overexpression of folate-binding receptors on their membrane.
24,25
 In order to evaluate the 
capacity to enhance the particle uptake of each targeting agent, separately and asymmetrically 
combined in one single particle, LNCaP cells were exposed to a fixed concentration (6 µg·mL
-1
) 
of each type of fluorescently labeled (in green) nanoparticles: NH2-MSN-CO2H, MSN-Fol, 
MSN-TPP and Fol-MSN-TPP respectively during 2 hours. After this time, the cells were gently 
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washed with PBS in order to remove non internalized particles. The number of cells which had 
engulfed fluorescent nanoparticles was determined by flow cytometry. In order to discard the 
particles which are simply attached on the cell membrane and not internalized inside, the 
external fluorescence was quenched adding trypan blue before cell counting. Thus, only the cells 
which have particles inside the inner space are counted as positive.  The same experiment was 
carried out in parallel using healthy pre-osteoblastic cells (MC3T3-E1), as model of cells which 
does not overexpress folate binding proteins on their surface, in order to evaluate the capacity of 
these nanocarriers to distinguish between tumoral cells and healthy ones. In the case of tumoral 
cells, the uptake was around 25% when the particles did not present any targeting moiety (NH2-
MSN-CO2H) whereas this value doubles when the particles were decorated with folic acid on 
one hemisphere (Figure 4).  Interestingly, particles functionalized only with TPP (MSN-TPP) 
almost triplicate the uptake in comparison with the untargeted particles, showing than 63% of the 
tumoral cell population engulfed these nanosystems, which are higher than the uptake achieved 
with the particles decorated with folic acid. The reason could be that these nanoparticles 
presented the highest positive charge at physiological pH and therefore, they present strong 
affinity by the negatively charged tumoral cell membrane. In any case, nanoparticles decorated 
with both targeting moieties (Fol-MSN-TPP) showed the highest uptake value (more than 90%) 
which indicates that the presence of these groups significantly enhances the uptake in this 
tumoral cell line. Regarding the nanoparticle uptake observed in healthy cells, only 10 % of the 
untargeted MSNs were captured by the cells while this value was significantly higher in the case 
of folic and TPP monofunctionalized MSN (Figure 4). Obviously, healthy cells also express 
folate receptors on their surface (although in lesser amount than tumoral cells) because this 
vitamin is essential and it participates in many biochemical pathways such as amino acids 
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metabolism and synthesis of RNA and DNA, among others. For this reason, the uptake of folic-
functionalized MSN was higher than untargeted MSN but it was lower than in the case of 
tumoral cells. Similar uptake has been yielded with MSN-TPP. This fact can be explained as in 
the previous case due to the electrostatic affinity between the positively charged nanoparticles 
and the negatively charged cell membrane.  Finally, the uptake of dual targeted MSN was 
slightly higher than the observed in mono-functionalized ones, but it was notably lower than the 
uptake achieved by tumoral cells (52% in healthy cells versus 91% in the case of tumoral cells). 
These results indicate the capacity of dual-targeted MSN to reach the inner space of tumoral cells 
in a selective manner which reflects its potential suitability for antitumoral therapy. 
 
Figure 4. Comparative nanoparticle uptake of MSN derivatives in LNCaP and MC3T3-E1 cell 
lines, respectively, and 2 hours of exposition time.  Data are mean ± SEM of 3 independent 
experiments performed at least in triplicate *p < 0.05 vs. NH2-MSN-CO2H; **p < 0.05 vs. 
MSN-Fol and NH2-MSN-CO2H;  #p < 0.05 vs. all conditions (Student's t-test). 
Page 19 of 31
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 20
 
In order to study with more detail, the particle fate within the tumoral cell as well as the 
efficacy of the organelle targeting moiety, cells were incubated with each type of nanoparticle in 
the same conditions and then, they were stained with blue DAPI as nuclei tracker and red 
Mitotracker® for labeling mitochondria. This staining protocol allows the qualitative 
determination by fluorescent microscopy of the particle location within the cells, detecting each 
fluorophore in separate channels, as has been reported elsewhere.
33
 In both cell lines, untargeted 
MSN were barely uptaked by the cells (Figure 5a and c). MSN-Fol showed higher uptake but 
significantly lower than the internalization achieved with MSN-TPP (Figure 5 b and d, versus e 
and g). Moreover, in the last case the presence of TPP on the particle surface caused that the 
nanoparticles were placed in close proximity with mitochondria, as can be observed by the 
overlapping between the green spots associated to the fluorescein of the nanoparticles and the red 
ones due to the mitochondria staining agent. Finally, dual-targeted MSN exhibited the highest 
accumulation and mitochondria localization in both cell lines (Figure 5 f and h) being higher in 
the case of tumoral cell line, which confirms the results obtained by flow cytometry. 
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Figure 5. Fluorescence microscopy images of cells exposed to a fixed concentration of the 
following MSN derivatives: NH2-MSN-CO2H a) and c), MSN-Fol b) and d), MSN-TPP e) and 
g), Fol-MSN-TPP f) and h). Blue color corresponds to cell nuclei, obtained using blue DAPI 
staining agent, red color corresponds to mitochondria, obtained employing red MitoTracker® 
and green dots correspond to MSN nanosystems due to the presence of fluorescein trapped 
within the silica matrix (White scale bars correspond to 200µm). 
The use of nanodevices as drug carriers for clinical applications requires that the designed 
material present excellent biocompatibility and absence of cytotoxicity. MSN is a biocompatible 
material which presents low toxicity, lack of immunogenicity and is degraded into non-toxic 
compounds (mainly silicic acid) in relatively short time periods.
34
 Despite its lack of toxicity, the 
surface modification of this material could provoke the apparition of toxicity due to the enhanced 
uptake within the cells. In order to evaluate the absence of toxicity, LNCaP and MC3T3-E1 cells 
were incubated with a significantly higher amount of functionalized MSNs (100 µg·mL-1) in cell 
culture medium during 24 hours. After this time, cell viability was determined using the 
standardized cell viability test by MTS reduction. The results showed that none of these empty 
materials exhibited cytotoxicity in both cell lines (Figure 6). 
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Figure 6. Cell viability studies with and without TOP loaded within the MSN for LNCaP (up) 
and MC3T3-E1 (down) cell lines, respectively and 48 hours of exposition time. *p < 0.05 vs. 
corresponding control without TOP (Student's t-test). 
In a parallel way, the capacity of these materials to deliver cytotoxic drugs in a selective 
manner to tumoral cells was evaluated employing MSN loaded with a cytotoxic compound, in 
this case topotecan (TOP). TOP is an inhibitor of DNA topoisomerase-I, which is an enzyme in 
charge to reduce the strain in the DNA chains during replication. The administration of this drug 
induces damages in the DNA located in the cell nucleus and also in the mitochondria causing the 
cell death. This drug present high antitumoral activity but it suffers instability at neutral and 
basic pH, losing its activity after few hours.
35
 Therefore, it is needed to administrate repeated 
dosages of this drug in order to maintain its concentration in blood, which induces the apparition 
of systemic toxicity. For these facts, TOP has been selected as drug model for this system.  Thus, 
TOP was loaded within MSN derivatives by soaking the particles in a saturated aqueous solution 
of TOP (3 mg·mL
-1
). The amount of loaded TOP was determined by the difference in fluorescent 
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of the loading solution before and after the MSN immersion, showing in all cases around 5% of 
TOP in weight. LNCap and MC3T3-E1 cells were exposed to a fixed concentration of TOP-
loaded MSN during 6 hours. After this time, the cells were gently washed with PBS in order to 
remove the non-internalized particles and they were incubated 48 hours more in cell culture 
medium. In the case of tumoral cell line, when cells were exposed to untargeted MSN or mono-
functionalized targeted MSN (MSN-Fol and MSN-TPP), cell viability descended around 35-40% 
in all cases (Fig. 6). Cell viability decrease was significantly higher in the case of dual-targeted 
MSN (Fol-MSN-TPP) which shows around 55% of cell viability reduction. The higher toxicity 
can be attributed to the enhanced uptake observed and also to the close proximity of the 
nanocarrier to mitochondria, which could enhance the efficacy of the released TOP, as has been 
described in other systems.
36
 It is important to point out that the particle concentration in all 
cases were very low (6 µg·mL-1) and the exposition time in each case were also short (6 hours), 
which indicate the great cytotoxic capacity of these nanocarriers. In the case of healthy cells, 
only a slight decrease in cell viability was observed in the case of dual-targeted MSN (11%). 
This fact can be attributed to the lower uptake observed in these cells in comparison with the 
tumoral cell line and also to the higher resistance of healthy cells to cytotoxic drugs. 
These data confirm the best performance of dual-targeted MSN in comparison with the mono-
functionalized ones, which indicates the excellent suitability of this strategy to enhance the 
efficacy of nanocarrier-based therapies.  
 
CONCLUSIONS 
In this work, a new strategy for the synthesis of asymmetrically functionalized dual targeted 
MSN has been presented. This method, based on the formation of Pickering emulsions, allows 
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the obtaining of large amounts of J-MSN which is a significant advantage compared with other 
reported procedures such as sputter coating or microfluidic techniques. As a proof of concept, 
folic acid and a triphenylphosphine derivative have been chosen as cellular and organelle 
targeting moieties, respectively, in order to study the effect of the asymmetric introduction of 
these groups on the particle surface. The achieved results indicate that the combination of both 
targeting agents each of them located in one hemisphere of the particle enhances their uptake in 
tumoral cells and induces the localization of the nanocarrier close to mitochondria which 
improve the efficacy of the transported drugs. This novel strategy can be easily adapted for the 
introduction of different targeting moieties on the MSN surface which can improve the arsenal of 
nanomedicines in the fight against cancer. 
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An easy method for the synthesis of asymmetrically targeted mesoporous silica nanocarriers able 
to perform sequential cell-organelle vectorization.   
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